tucatinib,trastuzumab deruxtecan
seagen,daiichi sankyo,astrazeneca
['lung', 'tucatinib', 'enhertu', 'breast']
 enhertu for me
yes more ild with enhertu but we know the risk varies with dz subtype. much higher in lung compared to breast tucatinib has real toxicities and lot of people have very high copays
takes time to get the drug
Partner physician at Cancer Specialists of North Florida , Jacksonsville. All views are my own . Not medical advice .